CVS Group Regulatory News (CVSG)

14 December 2012

CVS Group plc

("CVS" or the "Company")

Exercise of Share Options

CVS, one of the UK's leading providers of veterinary services, announces that it has received notification that on 14 December 2012, two of its directors, Simon Innes (Chief Executive) and Paul Coxon (Finance Director), together with certain other senior employees of the Company, exercised options at 0.2 pence per share over an aggregate 439,831 ordinary shares of 0.2 pence each in the Company ("New Shares"), under the CVS Group Long Term Incentive Plan 2009/2012. Simon Innes and Paul Coxon have exercised options over 223,482 and 78,944 ordinary shares, respectively.

Application will be made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 20 December 2012.

Following admission of the New Shares, the Company's issued share capital will be 57,164,918 ordinary shares of 0.2 pence each. The total number of voting rights in the Company will be 57,164,918. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

Following the above exercise, Simon Innes, a director of the Company, will be interested in 769,957 Ordinary Shares in the Company, representing an interest of 1.35 per cent in the total voting rights of the Company.

Following the above exercise, Paul Coxon, a director of the Company, will be interested in 363,944 Ordinary Shares in the Company representing an interest of 0.64 per cent in the total voting rights of the Company.

Contacts: